Cystic Fibrosis in Children Clinical Trials
2 recruiting trials for Cystic Fibrosis in Children. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Cystic Fibrosis in Children clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Duke University (1), Gelb, Arthur F., M.D. (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Discontinuation of GERD therapy (other, 1 trial), followed by spirometry.
Track Cystic Fibrosis in Children trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
GERD in Children With Cystic Fibrosis
The purpose of this study is to evaluate the prevalence of gastroesophageal reflux disease (GERD) symptoms in pediatric patients with cystic fibrosis using the Gastroesophageal...
Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis
Goal is to physiologically detect unsuspected small airways obstruction in children and adults with treated heterozygous and homozygous cystic fibrosis. Unsuspected refers to...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Cystic Fibrosis in Children, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Cystic Fibrosis in Children, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Cystic Fibrosis in Children, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.